STOCKS NEWS EUROPE-Barclays backs selling Novartis call options

[Reuters – UK Focus] – Barclays’ equity derivatives strategists back selling call options on Swiss drugmaker Novartis in order to maximise returns, saying they believe Novartis’ shares are overvalued. Shares in Novartis, … more

View todays social media effects on GCVRZ

View the latest stocks trending across Twitter. Click to view dashboard

See who Sanofi is hiring next, click here to view